The Comparative Immunotherapy Program led by Nicola Mason of the School of Veterinary Medicine at the University of Pennsylvania is redefining how therapies are tested, uniting human and veterinary medicine to move promising immunotherapies forward to fight cancer and autoimmune diseases. “Pet dogs develop diseases spontaneously in the same way as humans do,” Mason says. The research that laid the groundwork for the program is featured in the documentary “Shelter Me: The Cancer Pioneers,” which has been nominated for two Daytime Emmys.

Healing doesn’t end with treatment. As cancer survivorship grows, many continue to struggle with anxiety and depression – often in silence. A new review highlights how caring-healing modalities (CHMs) like mindfulness and peer support can build resilience and reduce emotional distress. These human-centered approaches shift focus from treatment to healing, helping survivors reclaim their sense of self. Rooted in empathy and emotional expression, CHMs offer a whole-person approach that meets the deep psychological needs often overlooked in survivorship care –especially among breast cancer survivors.

Researchers at Huntsman Cancer Institute found that lipids fuel growth in triple-negative breast cancer cells. High-fat diets like keto could unintentionally worsen outcomes for breast cancer patients with obesity.

Breast cancer (BRCA) remains the most common malignant cancer in women worldwide. Although a range of treatments exists, options with fewer side effects are still limited. SIGLEC15 (sialic acid-binding immunoglobulin-type lectin 15), an emerging immunosuppressive transmembrane protein, is highly expressed across many solid tumors, including BRCA. Understanding its role could help design therapies that overcome the drawbacks of current standards.